Latest News by Industry
DUBLIN--(BUSINESS WIRE)--Nov 11, 2022--
The "Monoclonal Antibodies in Veterinary Health Market Share, Size, Trends, Industry Analysis Report, By Animal Type, By Application, By End-Use, By Region, Segment Forecast, 2022 - 2030" report has been added to ResearchAndMarkets.com's offering.
According to this new study, the global monoclonal antibodies in veterinary health market size is expected to reach USD 2,629.6 million by 2030. The report gives a detailed insight into current market dynamics and provides an analysis of future market growth.
The industry is expanding due to the development of novel monoclonal antibodies and increasing the cost of pets, treatments for allergic conditions, and increasing incidences of cancer, especially in dogs. Additionally, it is anticipated that awareness of advanced veterinary therapeutic options is likely to complement market growth.
The main drivers for market growth are the rising prevalence of atopic dermatitis and the rising rate of pet adoption. Additionally, the growing demand for therapeutic antibodies for the treatment of dogs' allergy diseases also contributes to the industry expansion.
The COVID-19 lockdowns and supply chain disruptions had less of an impact on the animal health industry economy than on other industries. In contrast, traditional practices generate a majority of their revenues from selling their high-margin products, such as pharmaceuticals.
Monoclonal Antibodies In Veterinary Health Market Report Highlights
Market Dynamics
Drivers and Opportunities
Restraints and Challenges
Companies Mentioned
The publisher has segmented the monoclonal antibodies in veterinary health market report based on animal type, application, end-use, and region:
Monoclonal Antibodies In Veterinary Health, Animal Type Outlook (Revenue - USD Million, 2018 - 2030)
Monoclonal Antibodies In Veterinary Health, Application Outlook (Revenue - USD Million, 2018 - 2030)
Monoclonal Antibodies In Veterinary Health, End-Use Outlook (Revenue - USD Million, 2018 - 2030)
Monoclonal Antibodies In Veterinary Health, Regional Outlook (Revenue - USD Million, 2018 - 2030)
For more information about this report visit https://www.researchandmarkets.com/r/21854i
View source version on businesswire.com:https://www.businesswire.com/news/home/20221111005471/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: HEALTH VETERINARY OTHER HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 11/11/2022 12:20 PM/DISC: 11/11/2022 12:21 PM
http://www.businesswire.com/news/home/20221111005471/en